Abstract: A bidirectional electroosmotic pump may be provided. The bidirectional electroosmotic pump may be made of materials that are biocompatible and non-ferrous. The bidirectional electroosmotic pump may be part of an implantable medical device for the purpose of medicine delivery. The bidirectional electroosmotic pump may contain a working fluid and may facilitate the delivery of a separate payload fluid. In an exemplary embodiment, the bidirectional pump may contain bellows which may allow the pump to deliver the payload fluid through a series of valves and/or catheters. In another embodiment the bidirectional electroosmotic pump may contain a pump sensing mechanism to monitor the state of the pump.

Abstract: According to at least one exemplary embodiment, an implanted medical pump sensing and control system may be provided. The pump sensing and control system may include a pump management circuit board. The pump sensing and control system may further include an implanted mainboard within a device, which may be a multilayer PCB that houses the control, communication, and power systems for the entire implanted device. The implanted mainboard may include one or more of a processor, a voltage control circuit, and/or a pump control circuit. The implanted mainboard may further communicate with the pump management board, and thereby control either a unidirectional or bidirectional pump.

Abstract: A bidirectional electroosmotic pump may be provided. The bidirectional electroosmotic pump may be made of materials that are biocompatible and non-ferrous. The bidirectional electroosmotic pump may be part of an implantable medical device for the purpose of medicine delivery. The bidirectional electroosmotic pump may contain a working fluid and may facilitate the delivery of a separate payload fluid. In an exemplary embodiment, the bidirectional pump may contain bellows which may allow the pump to deliver the payload fluid through a series of valves and/or catheters. In another embodiment the bidirectional electroosmotic pump may contain a pump sensing mechanism to monitor the state of the pump.

Abstract: A bidirectional electroosmotic pump may be provided. The bidirectional electroosmotic pump may be made of materials that are biocompatible and non-ferrous. The bidirectional electroosmotic pump may be part of an implantable medical device for the purpose of medicine delivery. The bidirectional electroosmotic pump may contain a working fluid and may facilitate the delivery of a separate payload fluid. In an exemplary embodiment, the bidirectional pump may contain bellows which may allow the pump to deliver the payload fluid through a series of valves and/or catheters. In another embodiment the bidirectional electroosmotic pump may contain a pump sensing mechanism to monitor the state of the pump.

Abstract: An anti-malware application analyzes behavior of an executing process to identify ransomware. The anti-malware application detects an untrusted process requesting enumeration of a directory of user files and causes the untrusted process to initially operate on a decoy file that mimics the user files. If the behavior of the untrusted process with respect to the decoy file is indicative of ransomware, the process can be terminated without loss of the user files. The decoy file may be deployed in a way that is undetectable to the user.

Abstract: A pipe flashing protector for protecting the vulnerable joint between a vent pipe and the roof flashing for a building, house or other architectural structure to prevent wear and decay of the joint and more specifically to protect the joint from ultraviolet light, moisture, and debris.

Abstract: A pipe flashing protector for protecting the vulnerable joint between a vent pipe and the roof flashing for a building, house or other architectural structure to prevent wear and decay of the joint and more specifically to protect the joint from ultraviolet light, moisture, and debris.

Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as obesity, hyperlipidemia, hypercholesterolemia and diabetes and other related disorders and diseases, and may be useful for other diseases such as NASH, atherosclerosis, cardiovascular diseases, hypothyroidism, thyroid cancer and other disorders and diseases related thereto.

Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome.

Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as obesity, hyperlipidemia, hypercholesterolemia and diabetes and other related disorders and diseases, and may be useful for other diseases such as NASH, atherosclerosis, cardiovascular diseases, hypothyroidism, thyroid cancer and other disorders and diseases related thereto.